Clinical Trial Update: AK135 in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for AK135 in chemotherapy-induced peripheral neuropathy shows the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• AK135

Snippet

Sponsor: Akeso | Conditions: Chemotherapy-induced Peripheral Neuropathy (CIPN) | Phase 1 | Status: NOT_YET_RECRUITING